IMM 1.61% 31.5¢ immutep limited

challenge accepted, page-6

  1. 2,649 Posts.
    lightbulb Created with Sketch. 249
    Redfaces -

    Easy to see now why you would be cautious if PRR previously cost you money. I want to be cautious too, without PRR costing me money.

    Let me have a guess at the answers to a few of them, before he replies:

    1 a) "The results have been published and you can read them for yourself. They are statisically significant and the medical community was rightly excited"

    1 b)"The trials will roll into each other and be progressively funded"

    1 e) "No, we seek NDI status which will be accepted or rejected in terms of the nature and extent of our proposed trial, including assessment of the reults we have provided concerning our earlier phase II trial."

    2 a) "It is our intention to seek adequate funding, which efforts are currently underway, without the need to draw on the $12M facility"

    3) "Ian sought to have me involved before he formally became a consultant to the project, with which he has been long familiar and informally "involved". His involvement was a factor in my taking this role"

    b) "Ian makes himself available for consultation on request. He is an interested expert with a humanitarian desire to see CVac succeed"

    c) "Ian is not remunerated at all by PRR, so he was not offered options which are in effect, remuneration."

    The rest - too loaded and / or not telling.

    Hope he does choose to reply, at least in part. Be a bit surprised if he ventures full cost and funding estimates, but you never know, and looking forward to reading any reply.

 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.